Sonoporation by low-frequency and low-power ultrasound enhances chemotherapeutic efficacy in prostate cancer cells in vitro

Oncology Letters

Volumn 6, Issue 2, 2013, Pages 495-498

  Wang, Yu ^a   Bai, Wen Kun ^a   Shen, E ^a   Hu, Bing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Low energy ultrasound; Low frequency ultrasound; Microbubble; Mitoxantrone delivery

Indexed keywords

CALCEIN; MITOXANTRONE;

ARTICLE; CANCER CELL CULTURE; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CHEMOTHERAPY; CLONOGENIC ASSAY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MICROBUBBLE; PROSTATE CANCER; SONOPORATION; SUSPENSION CELL CULTURE; ULTRASOUND;

EID: 84879471509     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1389     Document Type: Article

References (24)

1. Hensel K, Mienkina MP and Schmitz G: Analysis of ultrasound fields in cell culture wells for invitro ultrasound therapy experiments. Ultrasound Med Biol 37: 2105-2115, 2011.
2. Husseini GA and Pitt WG: The use of ultrasound and micelles in cancer treatment, J Nanosci Nanotechnol 8: 2205-2215, 2008.
3. Casey G, Cashman JP, Morrissey D, etal: Sonoporation mediated immunogene therapy of solid tumors. Ultrasound Med Biol 36: 430-440, 2010.
4. Qin S, Caskey CF and Ferrara KW: Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering. Phys Med Biol 54: R27-R57, 2009.
5. van Wamel A, Kooiman K, Harteveld M, etal: Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation. J Control Release 112: 149-155, 2006.
6. Ohl CD, Arora M, Lkink R, de Jong N, Versluis M, Delius M and Lohse D: Sonoporation from jetting cavitation bubbles. Biophys J 91: 4285-4295, 2006.
7. Juffermans LJ, van Dijk A, Jongenelen CA, Drukarch B, Reijerkerk A, de Vries HE, Kamp O and Musters RJ: Ultrasound and microbubble-induced intra-and intercellular bioeffects in primary endothelial cells, Ultrasound Med Biol 35: 1917-1927, 2009.
8. Hoskins P, Thrush A, Martin K and Whittingam T (eds): Diagnostic Ultrasound: Physics and Equipment. 2nd Edition. Cambridge University Press, New York, NY, 2010.
9. Schlicher RK, Radhakrishna H, Tolentino TP, Apkarian RP, Zarnitsyn V and Prausnitz MR: Mechanism of intracellular delivery by acoustic cavitation. Ultrasound Med Biol 32: 915-924, 2006.
10. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
11. Siegel R, Ward E, Brawley O and Jemal A: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236, 2011.
12. Carles J, Castellano D, Climent MÁ, Maroto P, Medina R and Alcaraz A: Castration-resistant metastatic prostate cancer: current status and treatment possibilities. Clin Transl Oncol 14: 169-176, 2012.
13. Mellott AJ, Forrest ML and Detamore MS. Physical non-viral gene delivery methods for tissue engineering. Ann Biomed Eng41: 446-468, 2013.
14. Khanna S, Amso NN, Paynter SJ and Coakley WT: Contrast agent bubble and erythrocyte behavior in a 1.5-MHz standing ultrasound wave. Ultrasound Med Biol 29: 1463-1470, 2003.
15. Kinoshita M and Hynynen K: Key factors that affect sonoporation efficiency in in vitro settings: the importance of standing wave in sonoporation. Biochem Biophys Res Commun 359: 860-865, 2007.
16. Rodamporn S, Harris NR, Beeby SP, Boltryk RJ and Sanchez-Elsner T: HeLa cell transfection using a novel sonoporation system. IEEE Trans Biomed Eng 58: 927-934, 2011.
17. Bai WK, Wu ZH, Shen E, Zhang JZ and Hu B: The improvement of liposome-mediated transfection of pEGFP DNA into human prostate cancer cells by combining low-frequency and low-energy ultrasound with microbubbles. Oncol Rep 27: 475-480, 2012.
18. Hao Q, Liu Q, Wang X, Wang P, Li T and Tong WY: Membrane damage effect of therapeutic ultrasound on Ehrlich ascitic tumor cells. Cancer Biother Radiopharm 24: 41-48, 2009.
19. Lentacker I, Geers B, Demeester J, De Smedt SC and Sanders NN: Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved. Mol Ther 18: 101-108, 2010.
20. Sonoda S, Tachibana K, Uchino E, etal: Inhibition of melanoma by ultrasound-microbubble-aided drug delivery suggests membrane permeabilization. Cancer Biol Ther 6: 1276-1283, 2007.
21. Yoshida T, Kondo T, Ogawa R, etal: Combination of doxorubicin and low-intensity ultrasound causes a synergistic enhancement in cell killing and an additive enhancement in apoptosis induction in human lymphoma U937 cells. Cancer Chemother Pharmacol 61: 559-567, 2008.
22. Iwanaga K, Tominaga K, Yamamoto K, etal: Local delivery system of cytotoxic agents to tumors by focused sonoporation. Cancer Gene Ther 14: 354-363, 2007.
23. Maeda H, Tominaga K, Iwanaga K, etal: Targeted drug delivery system for oral cancer therapy using sonoporation. J Oral Pathol Med 38: 572-579, 2009.
24. Liu Y, Liu Z, Li T and Ye G: Ultrasonic sonoporation can enhance the prostate permeability. Med Hypotheses 74: 449-451, 2010.